Journal of Nuclear Medicine · 2024 · 31 citations · 16 references
MedicineNuclear MedicineOncologyHybrid ImagingMetastasisOncologic ImagingCancer BiomarkersLung CancerLymph Node MetastasisThoracic Oncology ImagingTumor CharacterizationTumor MarkersCancer Metastasis BiomarkersDiagnostic EfficiencyFibroblast Activation Protein ImagingLung Cancer Metastasis To Lymph NodesLymph Node Metastasis BiomarkersNon-small Cell Lung Cancer ImagingTherapeutic Target IdentificationTherapeutic Target Validation
Fibroblast activation protein (FAP) is a promising diagnostic and therapeutic target in various solid tumors. This study aimed to assess the diagnostic efficiency of <sup>68</sup>Ga-labeled FAP inhibitor (FAPI)–04 PET/CT for detecting lymph node metastasis in non–small cell lung cancer (NSCLC) and to investigate the correlation between tumor <sup>68</sup>Ga-FAPI-04 uptake and FAP expression. <b>Methods:</b> We retrospectively enrolled 136 participants with suspected or biopsy-confirmed NSCLC who underwent <sup>68</sup>Ga-FAPI-04 PET/CT for initial staging. The diagnostic performance of <sup>68</sup>Ga-FAPI-04 for the detection of NSCLC was evaluated. The final histopathology or typical imaging features were used as the reference standard. The SUV<sub>max</sub> and SUV<sub>mean</sub>, <sup>68</sup>Ga-FAPI–avid tumor volume (FTV), and total lesion FAP expression (TLF) were measured and calculated. FAP immunostaining of tissue specimens was performed. The correlation between <sup>68</sup>Ga-FAPI-04 uptake and FAP expression was assessed using the Spearman correlation coefficient. <b>Results:</b> Ninety-one participants (median age, 65 y [interquartile range, 58–70 y]; 69 men) with NSCLC were finally analyzed. In lesion-based analysis, the diagnostic sensitivity and positive predictive value of <sup>68</sup>Ga-FAPI-04 PET/CT for detection of the primary tumor were 96.70% (88/91) and 100% (88/88), respectively. In station-based analysis, the diagnostic sensitivity, specificity, and accuracy for the detection of lymph node metastasis were 72.00% (18/25), 93.10% (108/116), and 89.36% (126/141), respectively. Tumor <sup>68</sup>Ga-FAPI-04 uptake (SUV<sub>max</sub>, SUV<sub>mean</sub>, FTV, and TLF) correlated positively with FAP expression (<i>r</i> = 0.470, 0.477, 0.582, and 0.608, respectively; all <i>P</i> ≤ 0.001). The volume parameters FTV and TLF correlated strongly with FAP expression in 31 surgical specimens (<i>r</i> = 0.700 and 0.770, respectively; both <i>P</i> < 0.001). <b>Conclusion:</b><sup>68</sup>Ga-FAPI-04 PET/CT had excellent diagnostic efficiency for detecting lymph node metastasis, and <sup>68</sup>Ga-FAPI-04 uptake showed a close association with FAP expression in participants with NSCLC.
16
<sup>68</sup>Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Clemens Kratochwil, Paul Flechsig, Thomas Lindner et al. · Journal of Nuclear Medicine · 2019 · 1.4K citations · Full text
Medicine, Nuclear Medicine, Oncology +17
Frederik L. Giesel, Sebastian Adeberg, Mustafa Syed et al. · Journal of Nuclear Medicine · 2020 · 303 citations · Full text
Medicine, Nuclear Medicine, Oncology +17